Bill Meagher

Bill Meagher's focus with The Deal is on small and microcap equity finance, healthcare and biotechnology, PIPEs, and companies going public. His work has appeared in newspapers and magazines throughout California as well as on PBS, “60 Minutes,” ABC News and CNBC. Meagher has also written video scripts and produced national events for a non-profit educational organization and ghost written two books.

Recent Articles By The Author

Bioverativ Makes Splash in Trading Debut, Gaining 18% on Day One

Bioverativ Makes Splash in Trading Debut, Gaining 18% on Day One

Biogen spinoff Bioverativ proved healthy out of the gate, jumping from an open of $40 a share to a close of $47.35.

Patent Victory Secures Lilly Hold on Cancer Drug Until 2022

Patent Victory Secures Lilly Hold on Cancer Drug Until 2022

An appeals court in Indiana upheld Eli Lilly's patent regarding Alimta, a major cancer drug for Lilly, keeping Teva and other generic drug specialists at bay.

Marissa Mayer Stepping Down From Yahoo! Board of Directors

Marissa Mayer Stepping Down From Yahoo! Board of Directors

Marissa Mayer, a somewhat controversial figure at Yahoo!, is stepping down from its board of directors along with co-founder David Filo and others in light of its proposed Verizon sale.

U.S. Charges 3 Chinese Nationals With Insider Trading, Hacking Law Firms

U.S. Charges 3 Chinese Nationals With Insider Trading, Hacking Law Firms

Feds, SEC accuse Chinese IT company workers of hacking into law firms and of insider trading involving companies in mergers.

Hologic Agrees to Sell Blood Screening Business to Grifols for $1.85B

Hologic Agrees to Sell Blood Screening Business to Grifols for $1.85B

Hologic and Grifols have worked together since 1998 building a blood screening business, and now Hologic will sell its share to Grifols.